Global and Japan Immobilized Trypsin Market Insights, Forecast to 2027

Immobilized Trypsin provides a fast and convenient method for digesting a range of concentrations of purified protein or complex protein mixtures. Digested peptides are easily separated from the Immobilized Trypsin as they flow through the spin column into the collection tube. Immobilized Trypsin is easily removed from the peptide solution because the trypsin does not pass though the column frit. Trypsin is a proteolytic enzyme, which cleaves at the carboxyl side of positively charged Lysine (Lys) and Arginine (Arg). When these amino acids are followed by the nonpolar Proline (Pro), the digestion of the site is not efficient. When Lys and Arg are followed by acids [Aspartic Acid (Asp) and Glutamic Acid (Glu)] the digestion is also not as efficient.
North American is the largest consumption place, with a consumption market share nearly 45% in 2019. Following North American, Europe is the second with the market share of 28.39%.
Market competition is intense. Promega, Thermo Scientific, G-Biosciences, SignalChem and Takara, etc. are the leaders of the industry, and they hold key patents, with high-end customers. Top 5 occupied 3/5 of the market in 2019.
According to the form, the classification of Immobilized Trypsin includes 2 ml, 4ml, etc. In addition, the proportion of 2 ml in 2019 is about 70.63%.
Immobilized Trypsin is widely used for Academic & Research Institutes and Pharmaceutical Companies. The most proportion of Immobilized Trypsin is used for Academic & Research Institutes, and the proportion in 2019 is about 62.15%.

Market Analysis and Insights: Global and Japan Immobilized Trypsin Market
This report focuses on global and Japan Immobilized Trypsin market.
In 2020, the global Immobilized Trypsin market size was US$ 10 million and it is expected to reach US$ 14 million by the end of 2027, with a CAGR of 5.6% during 2021-2027. In Japan the Immobilized Trypsin market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Immobilized Trypsin Scope and Market Size
Immobilized Trypsin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Immobilized Trypsin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Immobilized Trypsin market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
2 ml
4 ml
Others

Segment by Application
Academic & Research Institutes
Pharmaceutical Companies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Promega
Thermo Scientific
G-Biosciences
SignalChem
Takara
GoldBio
Creative Enzymes
ProteoChem